APA (7th ed.) Citation

Uthman, L., Kuschma, M. C., Römer, G., Boomsma, M., Keßler, J., Hermanides, J., . . . Weber, N. C. (2021). Novel anti-inflammatory effects of canagliflozin involving Hexokinase II in lipopolysaccharide-stimulated human coronary artery endothelial cells. Cardiovascular drugs and therapy, 35(6), . https://doi.org/10.1007/s10557-020-07083-w

Chicago Style (17th ed.) Citation

Uthman, Laween, et al. "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-stimulated Human Coronary Artery Endothelial Cells." Cardiovascular Drugs and Therapy 35, no. 6 (2021). https://doi.org/10.1007/s10557-020-07083-w.

MLA (9th ed.) Citation

Uthman, Laween, et al. "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-stimulated Human Coronary Artery Endothelial Cells." Cardiovascular Drugs and Therapy, vol. 35, no. 6, 2021, https://doi.org/10.1007/s10557-020-07083-w.